Financial Statement (percentage) 4.1 7.4 (3.3) Net Profit from Normal Operations 74.5 73.5 1.0 1.4 Profit Margin from the performance (percentage) 4.1 4.0 0.1 Performance for the 6 months period ending on
million. If considered the profit margin from the normal operations of the first nine months of 2017 comparing to the first nine months of 2016, the Company earned the increased EBITDA profit margin from
0.38 0.04 11.76% Total Revenue For the nine-month period ended 30 September 2019, the Company and its subsidiaries earned a total revenue of THB 1,286.92 million, an increase of THB 228.07 million or
Baht The Company earned THB 226.5 MB and THB 224.6 MB in Q1/2020 and 2019 respectively, an increase in total revenue amount THB 1.8 MB, equivalent to 0.8% of total revenue and can be summarized as the
0.38 0.04 11.76% Total Revenue For the nine-month period ended 30 September 2019, the Company and its subsidiaries earned a total revenue of THB 1,286.92 million, an increase of THB 228.07 million or 2
which 19,946 MTHB earned from sales revenue. The sales revenue increased by 665 MTHB or 3% comparing to the year 2017. The increment mostly derived from improved Epichlorohydrin (“ECH”) and Caustic Soda
Analysis of the Company’s Performance for the year ended December 31, 2018 Total Revenue For the year ended 31 December 2018, the Company and its subsidiaries earned a total revenue of THB 1,422.61 million
14.67% Total Revenue For the three-month period ended 31 March 2019, the Company and its subsidiaries earned a total revenue of THB 424.07 million, an increase of THB 78.28 million or 22.64% from the same
% Total Revenue For the six-month period ended 30 June 2019, the Company and its subsidiaries earned a total revenue of THB 870.11 million, an increase of THB 172.08 million or 24.65% from the same period
Discussion and Analysis of the Company’s Performance for the Nine Months Ended 30 September 2018 Total Revenue For the nine-month period ended 30 September 2018, the Company and its subsidiaries earned a total